|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white powder (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 841.40 °C. @ 760.00 mm Hg (est)
|
| Flash Point: | 865.00 °F. TCC ( 462.70 °C. ) (est)
|
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
| BOC Sciences |
| For experimental / research use only. |
| D-Maltose monohydrate
|
| Carbosynth |
| For experimental / research use only. |
| D-Maltose monohydrate
|
| Charkit Chemical |
| MALTOSE
|
| Glentham Life Sciences |
| D-(+)-Maltose monohydrate, 95%
|
| Glentham Life Sciences |
| D-(+)-Maltose monohydrate, USP/NF grade
|
| Penta International |
| D-(+)-MALTOSE MONOHYDRATE POWDER FOOD GRADE
|
| Penta International |
| D-(+)-MALTOSE MONOHYDRATE POWDER USP/NF GRADE
|
| Pfanstiehl, Inc |
| Maltose, High Purity, Hydrate (Low Endotoxin), USP/NF
Odor: characteristic Use: Maltose is a disaccharide consisting of two glucose molecules with an a-1,4 glucosidic bond. Upon injection, it is only requires a minimal amount of insulin, having little impact influence on blood-sugar levels. Hence, it is commonly used to stabilize intravenous IG infusions, among other protein-based formulations. |
| Santa Cruz Biotechnology |
| For experimental / research use only. |
| D-Maltose, Monohydrate
|
| Sigma-Aldrich |
| For experimental / research use only. |
| D-(+)-Maltose monohydrate from potato, ≥99%
|
| TCI AMERICA |
| For experimental / research use only. |
| D-(+)-Maltose Monohydrate >98.0%(HPLC)
|
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for dextro-maltose monohydrate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for dextro-maltose monohydrate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| AIDS Citations: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 23615261 |
| National Institute of Allergy and Infectious Diseases: | Data |
| WGK Germany: | 3 |
| | (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;hydrate |
| Chemidplus: | 0006363537 |
| RTECS: | OO5250000 for cas# 6363-53-7 |
References:
| | (2R,3R,4R,5R)-2,3,5,6-tetrahydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;hydrate |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 23615261 |
| Pubchem (sid): | 135094996 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 4-O-a-D- | glucopyranosyl-D-glucose hydrate (1:1) | | 4-O-a-D- | glucopyranosyl-D-glucose monohydrate | | D- | glucose, 4-O-a-D-glucopyranosyl-, hydrate (1:1) | | D- | glucose, 4-O-a-D-glucopyranosyl-, monohydrate | | | maltose monohydrate | | D-(+)- | maltose monohydrate | | (2R,3R,4R,5R)-2,3,5,6- | tetrahydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanal;hydrate |
Articles:
|